Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/844079/sonnet-biotherapeutics-to-present-preclinical-data-on-son-080-for-chemotherapy-induced-peripheral-neuropathy-cipn-at-the-aacr-2024-annual-meeting
https://www.accesswire.com/841135/sonnet-biotherapeutics-announces-early-safety-data-from-the-company-s-phase-1b-2a-clinical-trial-of-son-080-in-chemotherapy-induced-peripheral-neuropathy-cipn-met-the-study-s-initial-pre-specified-objective
https://www.accesswire.com/837968/sonnet-biotherapeutics-announces-a-publication-demonstrating-safety-and-tolerability-of-son-1010-in-healthy-volunteers